Aryzta


Top-line weakness, bottom-line improvements

08/10/19 -"Mixed set of FY19 results, as the top line was weak but profitability improved, at last! North American revenue remains the main issue. "

Pages
38
Language
English
Published on
08/10/19
You may also be interested by these reports :
26/05/20
Weak, but better than expected Q3 thanks to North America. The strategic review and the massive pressure from a shareholder group led by the activist ...

26/05/20
The FY19/20 EPS is down due to the integration of the full-year figures. The company has confirmed its FY20/21 guidance without (yet) integrating the ...

19/05/20
Disappointing H1 driven by NGP. Reducing investments in this category was the company’s choice, but we believe it is a bad mid-term strategy. The ...

13/05/20
We have integrated the strong Q1 figures, but with no major changes in our 2020 expectations. The exceptional Q1 was aided by one-offs (stockpiling ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO